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A b s t r a c t  
The aim of this study is to evaluate the antidiabetic effect of methanolic extract of Habenaria 
plantaginea and its various fractions in different animal models. The effect of repeated oral 
administration of methanolic extract along with its n-hexane, ethyl acetate and n-butanol fractions on 
serum lipid profile and plasma enzyme levels in diabetic rats was also examined. The effect was 
found to be pronounced in n-butanol fraction. In oral glucose tolerance test, reduction of fasting 
blood glucose levels took place from 60 min on administration of methanolic extract and its various 
fractions. The n-butanol fraction has almost similar effect as that of standard drug Glibenclamide (10 
mg/kg b. w). After 15 days of treatment, n-butanol fraction showed maximum reduction of blood 
glucose levels (64.28 %).  Total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL) and 
very low density lipoprotein (VLDL) levels were found to be decreased by 38.98, 28.06, 56.26 and 
37.77% respectively in diabetic rats whereas, cardioprotective, high density lipoprotein (HDL) was 
increased by 31.65%. The n-butanol fraction also restored the altered plasma enzyme such as 
serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT) 
and alkaline phosphatase (ALP) levels to near normal. These results clearly indicate that n-butanol 
fraction of methanolic extract of Habenaria plantaginea possess high antidiabetic potential along 
with significant hypoglycaemic and hypolipidemic effects.  




Diabetes mellitus (DM) is an endocrine disorder that is characterized 
by hyperglycemia [1]. A number of investigations, of oral 
antihyperglycemic agents from plants used in traditional medicine, 
have been conducted and many of the plants were found with good 
activity [2]. The World Health Organisation (WHO) has also 
recommended the evaluation of the plants’ effectiveness in 
conditions where we lack safe modern drugs [3]. According to World 
Health Organisation projections, the diabetic population is likely to 
increase to 300 million or more by the year 2025 [4]. Currently 
available therapies for diabetes include insulin and various oral 
antidiabetic agents such as sulfonylureas, biguanides, α-glucosidase 
inhibitors, glinides, which are used as monotherapy or in 
combination to achieve better glycaemic regulation. Many of these 
oral antidiabetic agents have a number of serious adverse effects 
[5]. Despite advances in understanding of the disorder and the 
management, the mortality and morbidity due to this disease is 
increasing [6]. The focus has been shifted to treat the various 
ailments through plant-derived drugs due to their safety, efficacy, 
cultural acceptability and lesser side effects. 
Habenaria plantaginea belonging to the family Orchidaceae and is 
generally grown all over India, Nepal, Bangla Desh and South East 
Asia in tropical and sub-tropical environment [7]. It is used as folk 
medicines in Northern India to treat cough, asthma, helminthiasis, 
insanity and snake bite [8]. The plant has been used as the source 
of medicine for the treatment of tuberculosis and paralysis. It has 
been reported that various phytoconstituents such as flavonoids, 
cynogenetic glycosides, terpenoids and tannins are present in tuber 
root of Habenaria plantaginea [9]. 
To the best of our knowledge, no work on antidiabetic activity of of 
Habenaria plantaginea in streptozotocin-induced diabetic rats has 
been reported. Therefore, the present study was undertaken to 
evaluate the antidiabetic activity of Habenaria plantaginea in 
experimental animals. 
 
Materials and methods 
Plant material 
The roots of Habenaria plantaginea were collected in the month of 
November from the Trisulia forest, Nayagarh, Odisha, India and 
were authenticated by senior taxonomist Dr. P. C. Panda, Regional 
Plant Resource Centre, Bhubaneswar, Odisha. A voucher specimen 
of the herbarium has been deposited at the Department of 
Pharmacognosy, Siksha ‘O’ Anusandhan University, Bhubaneswar, 
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Preparation of plant extract and its fractions 
The roots were dried under shade and crushed into coarse powder. 
Coarse powder was extracted by cold maceration method using 
methanol. The extract thus obtained was concentrated in rotary 
flash vacuum evaporator and further dried in vacuum oven. The 
methanolic extract was suspended in water and subjected to 
fractionation with n- hexane, ethyl acetate and n-butanol. The 
fractions were concentrated using rotary evaporator and dried in 
vacuum oven and utilized for animal studies.  
Preliminary phytochemical screening 
The methanolic extract obtained from Habenaria plantaginea was 
subjected to various qualitative chemical tests for the identification 
of various plant constituents [10]. 
Experimental animals 
Wistar albino rats (150–200 g) and Wistar albino mice (20–25 g) of 
both sexes were obtained from the experimental animal facility of 
Siksha ‘O’ Anusandhan University, Bhubaneswar, Odisha. Before 
and during the experiment, rats were fed with standard diet. After 
randomization into various groups and before initiation of 
experiment, the rats were acclimatized for a period of 7 days under 
standard environmental conditions of temperature (25 ± 2º C), 
relative humidity (35-60%) and dark/light cycle (12/12h). Animals 
described as fasting were deprived of food and water for 16 h ad 
libitum. The conditions in the animal house and the study protocol 
were approved by Committee for the Purpose of Control and 
Supervision on Experiments on Animals (CPCSEA) vides 
registration no. 1171 / C/ 08 / CPCSEA.  
Sample collection 
Blood samples were collected by retro-orbital plexus puncture 
method and blood glucose levels were estimated using Accu-check 
Active Glucose Stripes in Accu-check Active Test Meter. 
Acute toxicity studies 
Healthy adult Wistar albino rats of either sex, starved overnight were 
divided into four groups (n = 6) and were orally fed with the 
methanolic extract of Habenaria plantaginea in increasing dose 
levels of 100, 500, 1000, 3000 and 5000 mg/kg body weight [11]. 
The rats were observed continuously for 2 h for behavioral changes 
and after a period of 24 and 72 h for any lethality or death. 
Induction of diabetes 
The Wistar albino rats of either sex of body weight of 150-200 g 
were kept fasting for 24 h and thereafter diabetes was induced by 
intra-peritoneal (i.p) injection of streptozotocin (STZ), freshly 
dissolved in citrate buffer (pH 4.5), immediately before use. STZ was 
given at a dose of 65 mg/kg body weight [12]. In order to avoid STZ 
induced hypoglycemic mortality, 5% glucose solution was given for 
24 h to STZ treated rats [13]. After 72 h of STZ administration, the 
blood glucose levels were measured and the rats showing blood 
glucose level greater than 220 mg/dl were considered to be diabetic 
and were used for the present study.  
Study of Habenaria plantaginea on normoglycaemic 
animal  
Animals were divided in five groups of six rats each and treated 
orally once in a day as follow: group I served as control; groups II, 
III, IV and V were administered 200 mg/kg/day of methanolic extract, 
n-hexane, ethyl acetate and n-butanol fraction of Habenaria 
plantaginea respectively using gastric tube under the sample 
experimental conditions [14]. 
Study of Habenaria plantaginea extract and fractions on 
glucose loaded rats (Oral Glucose Tolerance Test) 
The oral glucose tolerance test was performed as per the method of 
Shirwaikar [15]. In this method, rats were fasted for 16 h before and 
during the experiment. Rats were divided into five groups of six each 
and normal water (2 ml/kg, p.o), Glibenclamide (10 mg/kg, p.o) and 
suspensions of dried methanolic extract in 5% solution of tween80, 
n- hexane, ethyl acetate and and n- butanol fractions (200mg/kg, 
p.o) were administered to Gr. I,II, III, IV, V and VI respectively.  
Glucose (3 g/kg, p.o) was fed 30 min after the administration of 
extracts. Blood was withdrawn from retro orbital sinus. at 0, 30, 60 
and 120 min of glucose administration. The blood glucose levels 
were estimated using glucose oxidase-peroxidase reactive strips 
and a glucometer (Accucheck, Roche Diagnostics, USA) 
Study of Habenaria plantaginea on Streptozotocin-
induced diabetic rats (Acute study) 
The Wistar albino rats were divided into five groups (n=6). Group I 
served as solvent control which received normal water (2ml/kg, p.o) 
and group II received Glibanclamide (10 mg/kg, p.o) by oral route of 
administration.  The suspensions of methanolic extract and its 
fractions at the dose of 200 mg/kg body weight were administered to 
Gr. III, IV, V and VI respectively in a similar manner. The blood 
samples were collected through tail vein puncturing with hypodermic 
needle and blood glucose levels were measured at 0, 1, 2, 4, 8 and 
24 h of administration of single dose for acute study. 
Study of Habenaria plantaginea on Streptozotocin-
induced diabetic rats (Long term study) 
Animals were divided into five groups of six rats each. The extract 
was administered for 15 days. Group I served as the  control, which 
were administered normal water daily and group II diabetic rats were 
administered standard drug Glibenclamide (10 mg/kg, p.o) for 15 
days. 
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Group III, IV and V diabetic rats were administered Habenaria 
plantaginea methanolic extract and its various fractions at the dose 
of 200 mg/kg respectively. The antidiabetic effect of Habenaria 
plantaginea extract and its fractions was determined by measuring 
fasting blood glucose levels on days 1, 3, 5, 7 and 15.  
Estimation of biochemical parameters 
Blood was collected on 15th day from retro-orbital plexus of the 
overnight fasted rats under light ether anaesthesia and kept aside 
for half an hour for clotting. Serum was separated by centrifuging 
the sample at 6000 rpm for 20 min. The serum was analysed for 
total protein [16], total cholesterol [17], TG, LDL, VLDL, HDL [18], 
SGPT, SGOT and ALP [19]. 
Statistical analysis 
All the values of fasting blood glucose level and biochemical 
estimations were expressed as mean± standard deviation (SD) and 
analyzed for ANOVA followed by Dunnet’s t -test. Differences 







Preliminary phytochemical screening 
The phytochemical screening of methanolic extract of Habenaria 
plantaginea revealed the presence of flavonoids, phenolics, steroids 
and  triterpenoides. 
Acute toxicity studies 
The acute toxicity study result of the methanolic extract of 
Habenaria plantaginea on mice showed no mortality and no 
significant gross behavioural changes observed even at a higher 
dose level of 5 g/kg b. w. Therefore, it is evidenced that the plant 
extracts are non-toxic in nature and hence found suitable to explore 
their blood glucose lowering activity in different animal models. 
Antidiabetic activity in normal, glucose loaded and 
Streptozotocin-induced diabetic rats 
The antidiabetic effect of extract of Habenaria plantaginea on the 
fasting blood sugar level of normal, glucose loaded and 
Streptozotocin-induced diabetic rats  is shown in Table 1, 2, 3 and 4. 
In normal animals, significant (P<0.05 to p<0.01) reduction in the 
blood glucose levels (BGL) was observed by the methanolic extract 




Table.1.  Effect of Habenaria plantaginea on blood glucose levels in normal rats. 
Groups & 
Treatment 
Blood Glucose Levels (mg/dl) 






















































































Values expressed as mean ± SD (n=6). Treatment was done for 8 hours. The data were statistically analysed by one- 
way ANOVA, followed by Dunnet’s t-test. p values less than 0.05 were considered significant. *: p <0.05; **: p<0.01 
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The maximum hypoglycaemic activity was induced by n-butanol 
fraction at 200 mg/kg dose level (32.17%). Hypoglycaemic activity 
of Glibenclamide (10 mg/kg), the reference drug, was found to be 
35.16%. However, the effects of n-hexane and ethyl acetate 
fractions (200 mg/kg) were found to be 11.38 and 25.58% 
respectively. 
The methanolic extract and its various fractions significantly 
improved the glucose tolerance test up to 120 min (Table 2). The 
n-butanol fraction of Habenaria plantaginea at the dose of 200 
mg/kg showed maximum reduction of BGL by 32.97% from 
control value in 120 min. Glibenclamide improved the glucose 
tolerance test up to 120 min. (34.59%). The methanolic extract, n- 
hexane and ethyl acetate fractions significantly improved the 




Table.2. Effect of Habenaria plantaginea on blood glucose levels in glucose loaded rats. 
Groups & Treatment Blood Glucose Levels (mg/dl) 
0 min 30 min 60 min 90 min 120 min 
Normal control(2ml/kg) 94±4.22 136.5±3.95 132±5.60 128±3.28 124.85±4.65 














































Values expressed as mean ± SD (n=6). The data were statistically analyzed by one- way ANOVA, followed by Dunnet’s t-test. P 
values less than 0.05 were considered. 
 
Table. 3.  Effect of Habenaria plantaginea on blood glucose levels in Streptozotocin-induced diabetic rats (Acute study) 
Groups & 
Treatment Blood Glucose Levels (mg/dl) 
0 h 1 h 2 h 4 h 8 h 24 h F values 
Normal 
control (2ml/kg) 
231.15±8.68 235.84±17.62 238.50±8.98 234.66±17.38 235.38±15.50 250.2±16.08 0.44 
Glibenclamide 
(10 mg/kg) 











 (200 mg/kg) 











254.46±15.18 246.5±13.14 214.66±15.84** 178.16±13.16** 152.75±8.80** 
(39.97) 
244.76±12.14 168.75 
Values expressed as mean ± SD (n=6). The data were statistically analyzed by one- way ANOVA, followed by 
Dunnet’s t-test. P values less than 0.05 were considered significant. *: p <0.05; **: p <0.01. Figure in parenthesis 
indicates % fall in BGL as compared to 0 hour. 
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The n-butanol fraction at a dose level of 200 mg/kg b.w. produced 
the maximum fall of 39.97 % in the BGL of diabetic rats after 8 h of 
treatment (Table 3).The Glibenclamide at a dose of 10 mg/kg b.w. 
resulted in 41.63% fall in BGL of diabetic rats, where as methanolic 
extract, n-hexane and ethyl acetate fractions at the tested dose 
level produced the maximum fall of 25.57, 12.70 and 36.92% 
respectively in the BGL of diabetic rats after 8 h of treatment. 
In the long term study, n- butanol fraction (200 mg/kg) registered 
64.28% reduction of BGL at the end of 15 days. The standard drug, 
Glibenclamide (10 mg/kg) exhibited maximum reduction of BGL by 
66.5%, while methanolic extract, n-hexane, ethyl acetate showed 
48.53, 34.24 and 56.58% reduction of BGL. The most effective 
percentage reduction in BGL was observed in the animals treated 
by n-butanol fraction at 200 mg/kg body weight. 
 
 
Table. 4. Effect of Habenaria plantaginea on blood glucose levels in Streptozotocin-induced diabetic rats (Long term 
study). 
Groups & Treatment 
Blood Glucose Levels (mg/dl) 
Day 0 Day 3 Day 5 Day 7 Day 15 F value 
Diabetic Control 
(2ml/kg) 235.45±10.39 238.5±9.48 228.5±9.81 232.5±7.42 241.24±8.30 1.51 
Glibenclamide 











 (200 mg/kg) 








(200 mg/kg) 240.15±8.32 189.25±9.00** 149.33±10.30** 123±7.90** 
85.76±8.21** 
(64.28) 214.67 
Values expressed as mean ± SD (n=6). The data were statistically analyzed by one- way ANOVA, followed by 
Dunnet’s t-test. P values less than 0.05 were considered significant. *: p <0.05; **: p <0.01. Figure in parenthesis 
indicates % fall in BGL as compared to day. 
 
Biochemical parameters 
The significant differences were observed in serum lipid profiles 
as TC,TG, HDL, LDL, VLDL, SGOT, SGPT and ALP (Table 5) in 
methanolic  extract  of Habenaria plantaginea and its different 
fractions treated diabetic animals at 200 mg/kg after 15 days of 
treatment, when compared with that of solvent control rats 
(p<0.05 to p < 0.01). 
The n-butanol, ethyl acetate and n-hexane fraction of methanolic 
extract of Habenaria plantaginea reduced TC, TG, LDL and 
VLDL by 38.98, 28.06, 56.28, 37.77;  30.24, 22.2, 50.61, 25 and 
24.86, 17.58, 44.59, 23.05% respectively. The methanolic 
extract of the plant registered 28.71, 21.59, 46.62 and 19.35% 
reduction in TC, TG, LDL and VLDL, while Glibenclamide 
showed the reduction of 48.55, 44.06, 63.69 and 47.27% 
respectively (Figure.5). There was an increase of pecentage in 
HDL cholesterol by 31.65, 25.21, 22.40 and 26.34 in n-butanol, 
ethyl acetate, n-hexane and methanolic extract treated diabetic 
groups respectively. 
The elevated levels of SGPT, SGOT and ALP were significantly 
decreased by 34.81, 33.59, 33.43, 38.29; 28.02, 18.48, 13.77, 
9.71and 35.4, 29.56, 24.83, 28.44% on treatment with n-butanol, 
ethyl acetate, n-hexane and methanolic extract respectively, 
where as SGPT, SGOT and ALP levels of Glibenclamide treated 
rats were decreased by 54.46, 31.23 and 44.57 after 15 days 
treatment. The most effective percentage reduction in serum 
lipids, SGOT, SGPT and ALP was observed in n-butanol treated 
rats.  
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Values expressed as mean ± SD (n=6). Treatment was done for 15 days. The data were statistically analysed by one- 




Diabetes mellitus is possibly the world’s largest growing metabolic 
disease and as the knowledge on the heterogeneity of this 
disorder is advanced, the need for more appropriate therapy 
increases [20]. Considerably, large number of 
hypoglycemic/antidiabetic plants and herbs are known through 
folkloric use but their introduction into modern therapy waits 
pharmacological testing by modern methods. The study of such 
medicines might offer a natural key to unlock a diabetologist’s 
pharmacy for the future. 
In the present study, treatment with Habenaria plantaginea 
methanolic extract and it’s ethyl acetate and n-butanol 
fractions(200 mg/kg b.w.) in normoglycaemic rats produced 
significant decrease in blood glucose level. The hypoglycemic 
effect may be due to increased secretion of insulin from the β-
cells of the pancreas, i.e., pancreatotrophic action [21].  The 
results were comparable with that of Glibenclamide, which acts by 
stimulation of insulin release, thus, further confirming that the 
extract lowers the blood glucose by a pancreatotrophic action 
[22]. 
In normal and glucose loaded rats, hypoglycaemic action of the n- 
butanol fraction of methanolic extract is more than the other 
fractions and has almost similar effect as of synthetic drug 
Glibenclamide especially during OGTT and Streptozotocin-
induced diabetes. 
Prolonged administration of methanolic extract of Habenaria 
plantaginea leads to significant reduction in blood glucose level, 
which is in agreement with other study [23].  
The mechanism by which Streptozotocin brings about its diabetic 
state includes selective destruction of pancreatic β-cells which 
make the cells less active leading to poor sensitivity of insulin for 
glucose uptake by the tissues [24,25]. The increased levels of 
plasma glucose in STZ-induced diabetic rats were lowered by the 
administration of Habenaria plantaginea extracts. The reduced 
glucose levels suggested that the extracts might exert insulin-like 
effect on peripheral tissues by either promoting glucose uptake 
metabolism by inhibiting hepatic gluconeogenesis or by 
absorption of glucose into the muscle and adipose tissues 
through the stimulation of revitalisation of the remaining β-cells 
[26,27]. Another possible mechanism by which Habenaria 
plantaginea brings about its hypoglycemic action may be by 
potentiating the insulin effects of plasma by increasing either the 
pancreatic secretion of insulin from the existing β-cells or by its 
release from the bound form [28]. 
The total protein content in serum was significantly lowered in the 
solvent (water) treated group, but it returned to nearly normal in 
the extract treated groups. Normal liver functioning was affected 
due to decreased protein synthesis in diabetic rats while it was 
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almost restored in the plant extract treated animals. Serum 
enzymes including SGPT, SGOT and ALP were used in the 
evaluation of hepatic disorders. An increase in these enzyme 
activities reflects active liver damage. Inflammatory hepatocellular 
disorders result in extremely elevated transaminase levels [29]. 
The increase in the availability of plasma SGPT, SGOT and ALP 
indicated liver dysfunction [30]. Therefore, an increase in the 
presence of SGPT, SGOT and ALP in plasma might be mainly 
due to the leakage of these enzymes from the liver cytosol into 
the blood stream [31]. On the other hand, treatment of the 
diabetic rats with the subjected plant extracts caused reduction of 
these enzymes in plasma when compared to the solvent group 
and consequently reduce the liver damage. A significantly (p < 
0.01) elevated activity of SGPT was observed in the solvent 
control rats suggesting hepatic dysfunction in these animals. 
Treatment of methanolic, n-hexane, ethyl acetate and n-butanol 
fractions and Glibenclamide significantly reduced hepatic 
dysfunction (p<0.01).  
Diabetes is associated with hyperlipidemia [32].  High levels of TC 
and more importantly LDL cholesterol are major coronary risk 
factors whereas several studies have showed that an increase in 
HDL cholesterol is associated with a decrease in coronary risk. 
Most of the drugs that decrease total cholesterol also decrease 
HDL cholesterol [33]. However, it is interesting to found that in the 
present study the dose of 200 mg/kg of body weight of the 
methanolic and n-butanol fractions not only lowered the TC, TG, 
and LDL, but also enhanced the cardio protective lipid HDL after 
15 days treatment. This would definitely reduce the incidence of 
coronary events, which is the major cause of morbidity and 
deaths in diabetic subjects [34].  
Under normal conditions, the enzyme lipoprotein lipase 
hydrolyses triglycerides. Diabetes mellitus results in failure to 
activate this enzyme thereby causing hypertriglyceridemia. As the 
test extracts reduced the VLDL, TC and TG, hence it might be 
presumed that the methanolic  extracts are responsible for the 
enhancement of transcription of lipoprotein lipase similar to that of 
insulin.It is well known that LDL plays an important role in 
arteriosclerosis and that hypercholesterolemia is associated with 
a defect relating to the lack of LDL receptors. The decrease of 
total cholesterol and LDL levels achieved by administration of 
methanolic extract, demonstrates a possible protection against 
hypercholesterolemia and the harm this condition brings about. 
 
Conclusions 
The results obtained in the study indicate that n-butanol fraction of 
methanolic extract of Habenaria plantaginea showed significant 
blood glucose lowering activity, both in the normal as well as STZ-
induced diabetic rats. The administration of methanolic extract 
and its various fractions to the diabetic rats for 15 days not only 
significantly lowered the fasting blood glucose level of the diabetic 
animals but also lowered the lipid profiles, SGOT and SGPT 
levels. The blood glucose lowering and hypolipidemic effects are 
thus protective mechanism against the development of 
atherosclerosis, hyperlipidaemia and hyperglycemia, which are 
common in diabetes. It also caused reversal of the damage of 
liver observed in diabetic animals by lowering of the SGOT and 
SGPT levels. Among methanolic extract and its all tested 
fractions, n-butanol fraction exhibited most potent antidiabetic and 
hypolipidemic effect. It was found to have a high margin of safety 
and thus Habenaria plantaginea seems to have a promising value 
for the development of a potent phytomedicine for diabetes. 
Further studies are needed to isolate and characterize the 
chemical constituents of the methanolic extract of Habenaria 
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